Apnea of Prematurity Treatment
Introduction to Caffeine Citrate
- Caffeine citrate improves pulmonary function in infants with chronic lung disease, according to the American Thoracic Society, by facilitating weaning from mechanical ventilation and potentially reducing the need for intubation 1
Respiratory Support and Benefits
- The use of caffeine citrate in premature infants (28-32 weeks gestational age) is supported by evidence, although the specific citation for this fact is not provided, it is implied to be effective in this population
- Improves survival outcomes and reduces the risk of bronchopulmonary dysplasia, however the specific citation for this is not provided